Treatment strategies We defined treatment strategies based on prescription for GLP-1RA in January 2013 (baseline, T0 for the first target trial): patients who initiated any GLP-1RAs (albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, semaglutide and tirzepatide) were classified as initiators and all others were classified as noninitiators
This activation of the PI3K pathway could trigger Protein Kinase B (Akt), a potential enzyme within this pathway that may influence the movement of glucose transporters to the plasma membrane, potentially increasing the uptake of glucose by cells
[DOI] [PubMed] [Google Scholar] 43.Mahmoud S.H., Yassein S.N
(2018) Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer
Safety and tolerability of linagliptin in patients with type 2 diabetes: a comprehensive pooled analysis of 22 placebo-controlled studies
It is also a gut hormone that suppresses appetite and increases satiety, but may also reduce gastrointestinal side effects and reduce muscle loss, per CNBC
